Company profilePharmaceutical#135 of 1,318 in Pakistan✓ No DRAP alerts

Evolution Pharmaceuticals (Pvt.) Ltd.

Pharmaceutical company · 120 brands · 88 molecules

120 registered products 47 pharmaceutical brands 88 distinct molecules 0 DRAP alerts

Company overview

120
registered products
47
pharmaceutical brands
88
distinct molecules
0
therapeutic classes
0
DRAP alerts

Evolution Pharmaceuticals (Pvt.) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 120 product registrations across 88 distinct molecules. It is the 135th largest registrant in Pakistan by product count. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Evolution

104 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

103
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
2026103

Top molecules by brand count

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official138 products · Rs 44.96 – Rs 8,111.74
Median across source: Rs 421.35

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 241 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
MEDISURE LABORATORIES PAKISTAN (PVT.) LTD. holds 45 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirArtemetherAscorbic AcidAtorvastatinAtorvastqatin Usp
NABIQASIM INDUSTRIES (PVT) LTD. holds 165 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir

Get the full profile for Evolution

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.